| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Maria Ciemerych-Litwinienko | Q16574722 |
| Barbara Świerczek | Q114432612 | ||
| Ciemerych MA | Q70526206 | ||
| Karolina Archacka | Q79714085 | ||
| P2860 | cites work | Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy | Q24310537 |
| Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells | Q24616059 | ||
| Myogenic potential of adipose-tissue-derived cells | Q79851534 | ||
| Generation of skeletal muscle from transplanted embryonic stem cells in dystrophic mice | Q81831801 | ||
| Generation of skeletal muscle stem/progenitor cells from murine induced pluripotent stem cells | Q83023116 | ||
| Restricted myogenic potential of mesenchymal stromal cells isolated from umbilical cord | Q83961676 | ||
| Bidirectional induction toward paraxial mesodermal derivatives from mouse ES cells in chemically defined medium | Q84510423 | ||
| Retinoic acid enhances skeletal myogenesis in human embryonic stem cells by expanding the premyogenic progenitor population | Q84514067 | ||
| Multiple insights from myogenic cell transplants | Q87920944 | ||
| Derivation of multipotent mesenchymal precursors from human embryonic stem cells | Q24813785 | ||
| Efficient differentiation of embryonic stem cells into mesodermal precursors by BMP, retinoic acid and Notch signalling | Q27303651 | ||
| Efficient and reproducible myogenic differentiation from human iPS cells: prospects for modeling Miyoshi Myopathy in vitro | Q27324593 | ||
| Establishment in culture of pluripotential cells from mouse embryos | Q27860625 | ||
| Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors | Q27860937 | ||
| Induction of pluripotent stem cells from adult human fibroblasts by defined factors | Q27860967 | ||
| Reprogramming with Small Molecules instead of Exogenous Transcription Factors | Q28084394 | ||
| Requirement for Wnt3 in vertebrate axis formation | Q28141064 | ||
| Neural crest regulates myogenesis through the transient activation of NOTCH | Q28237632 | ||
| Generation of functional human pancreatic β cells in vitro | Q28249536 | ||
| Human embryonic stem cell lines derived from single blastomeres | Q28259674 | ||
| Differentiation of pluripotent stem cells to muscle fiber to model Duchenne muscular dystrophy | Q28265827 | ||
| Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133 | Q28286875 | ||
| Pitx2 defines alternate pathways acting through MyoD during limb and somitic myogenesis | Q28296753 | ||
| In vitro modeling of paraxial mesodermal progenitors derived from induced pluripotent stem cells | Q28484548 | ||
| β-catenin is essential for efficient in vitro premyogenic mesoderm formation but can be partially compensated by retinoic acid signalling | Q28504791 | ||
| Divergent functions of murine Pax3 and Pax7 in limb muscle development | Q28505611 | ||
| Requirement for beta-catenin in anterior-posterior axis formation in mice | Q28507627 | ||
| MyoD or Myf-5 is required for the formation of skeletal muscle | Q28510042 | ||
| Beta-catenin is essential and sufficient for skeletal myogenesis in P19 cells | Q28511049 | ||
| CXCR4 and Gab1 cooperate to control the development of migrating muscle progenitor cells. | Q28511299 | ||
| Mixl1 is required for axial mesendoderm morphogenesis and patterning in the murine embryo | Q28588082 | ||
| Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene | Q28592173 | ||
| The Wnt/beta-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis | Q28594489 | ||
| High-resolution genome-wide mapping of transposon integration in mammals | Q28769896 | ||
| Pdgfrα and Flk1 are direct target genes of Mixl1 in differentiating embryonic stem cells. | Q29347285 | ||
| Derivation of pluripotent epiblast stem cells from mammalian embryos | Q29614819 | ||
| Immunogenicity of induced pluripotent stem cells | Q29616185 | ||
| Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development | Q29617978 | ||
| Embryonic stem cell trials for macular degeneration: a preliminary report | Q29620714 | ||
| Asymmetric self-renewal and commitment of satellite stem cells in muscle. | Q30489194 | ||
| Derivation of myogenic progenitors directly from human pluripotent stem cells using a sphere-based culture | Q30577387 | ||
| Functional substitution by TAT-utrophin in dystrophin-deficient mice | Q33455443 | ||
| Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin. | Q33509377 | ||
| Clonal characterization of rat muscle satellite cells: proliferation, metabolism and differentiation define an intrinsic heterogeneity. | Q33521883 | ||
| Derivation and FACS-mediated purification of PAX3+/PAX7+ skeletal muscle precursors from human pluripotent stem cells | Q42273400 | ||
| Pax3 synergizes with Gli2 and Zic1 in transactivating the Myf5 epaxial somite enhancer | Q42813521 | ||
| Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy. | Q42819955 | ||
| Pax3/Pax7 mark a novel population of primitive myogenic cells during development | Q42863008 | ||
| Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death | Q43409060 | ||
| Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma | Q43735101 | ||
| Efficient derivation and inducible differentiation of expandable skeletal myogenic cells from human ES and patient-specific iPS cells. | Q45876520 | ||
| Pax-3 expression in segmental mesoderm marks early stages in myogenic cell specification | Q46458507 | ||
| Hope for regenerative treatments: toward safe transplantation of human pluripotent stem-cell-based therapies. | Q47570573 | ||
| Human multipotent adipose-derived stem cells restore dystrophin expression of Duchenne skeletal-muscle cells in vitro. | Q50657951 | ||
| Direct isolation of satellite cells for skeletal muscle regeneration. | Q50756094 | ||
| Mouse chimaeras revisited: recollections and reflections. | Q50852783 | ||
| Functional skeletal muscle regeneration from differentiating embryonic stem cells. | Q51966818 | ||
| A comparative analysis of Meox1 and Meox2 in the developing somites and limbs of the chick embryo. | Q51974996 | ||
| Regulation of Pax-3 expression in the dermomyotome and its role in muscle development | Q52217598 | ||
| Directed Myogenic Differentiation of Human Induced Pluripotent Stem Cells. | Q53506908 | ||
| In vitro growth and differetiation of clonal populations of multipotential mouse clls derived from a transplantable testicular teratocarcinoma. | Q53778055 | ||
| Canonical Wnt signaling regulates Foxc1/2 expression in P19 cells. | Q54463714 | ||
| Surface antigen differentiation during human myogenesis in culture | Q59088636 | ||
| The molecular basis of muscular dystrophy in the mdx mouse: a point mutation | Q69514522 | ||
| The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells | Q69541163 | ||
| Pax-3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells | Q72374761 | ||
| A Pax3/Dmrt2/Myf5 regulatory cascade functions at the onset of myogenesis | Q33549660 | ||
| Retinoic-acid signalling in node ectoderm and posterior neural plate directs left-right patterning of somitic mesoderm | Q33586341 | ||
| Signaling gradients during paraxial mesoderm development | Q33687019 | ||
| GSK3: a multifaceted kinase in Wnt signaling | Q33712410 | ||
| The muscle satellite cell at 50: the formative years. | Q33995094 | ||
| An alternative pluripotent state confers interspecies chimaeric competency | Q34043928 | ||
| Humanized Mice Reveal Differential Immunogenicity of Cells Derived from Autologous Induced Pluripotent Stem Cells | Q34044685 | ||
| Turning straw into gold: directing cell fate for regenerative medicine | Q34169386 | ||
| Chemically defined generation of human cardiomyocytes | Q34216549 | ||
| Building muscle: molecular regulation of myogenesis. | Q34251533 | ||
| Activation of muscle-specific genes in pigment, nerve, fat, liver, and fibroblast cell lines by forced expression of MyoD. | Q34290920 | ||
| Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice | Q34350930 | ||
| Myogenin gene disruption results in perinatal lethality because of severe muscle defect | Q34356598 | ||
| Gene regulatory networks and transcriptional mechanisms that control myogenesis | Q34404096 | ||
| A Pax3/Pax7-dependent population of skeletal muscle progenitor cells | Q34412889 | ||
| Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. | Q34420945 | ||
| Control of somite patterning by signals from the lateral plate | Q34424021 | ||
| Selective development of myogenic mesenchymal cells from human embryonic and induced pluripotent stem cells | Q34511100 | ||
| Myogenic factors that regulate expression of muscle-specific microRNAs | Q34531532 | ||
| Directed in vitro myogenesis of human embryonic stem cells and their in vivo engraftment | Q34972891 | ||
| A novel genetic hierarchy functions during hypaxial myogenesis: Pax3 directly activates Myf5 in muscle progenitor cells in the limb | Q35018054 | ||
| Myoblast fusion: lessons from flies and mice | Q35691569 | ||
| Functional myogenic engraftment from mouse iPS cells. | Q35735727 | ||
| The skeletal muscle satellite cell: still young and fascinating at 50 | Q35767940 | ||
| Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle | Q35835194 | ||
| Assessment of the myogenic stem cell compartment following transplantation of Pax3/Pax7-induced embryonic stem cell-derived progenitors | Q35886706 | ||
| Subtle neuromuscular defects in utrophin-deficient mice | Q36254585 | ||
| Myogenin is required for late but not early aspects of myogenesis during mouse development | Q36382447 | ||
| Concise review: no breakthroughs for human mesenchymal and embryonic stem cell culture: conditioned medium, feeder layer, or feeder-free; medium with fetal calf serum, human serum, or enriched plasma; serum-free, serum replacement nonconditioned med | Q36775037 | ||
| MyoD and myogenin act on the chicken myosin light-chain 1 gene as distinct transcriptional factors. | Q36826381 | ||
| From planarians to mammals - the many faces of regeneration. | Q37098806 | ||
| WNT3A promotes hematopoietic or mesenchymal differentiation from hESCs depending on the time of exposure | Q37133638 | ||
| Good manufacturing practice and clinical-grade human embryonic stem cell lines | Q37218542 | ||
| Embryonic stem cells and the problem of directed differentiation | Q37392920 | ||
| Cell cycle regulation during proliferation and differentiation of mammalian muscle precursor cells. | Q37883210 | ||
| Factors regulating pluripotency and differentiation in early mammalian embryos and embryo-derived stem cells. | Q37962741 | ||
| Mouse and human pluripotent stem cells and the means of their myogenic differentiation. | Q38037456 | ||
| Regulation of acetylcholine receptor channel function during development of skeletal muscle. | Q38191619 | ||
| Molecular and cellular regulation of skeletal myogenesis | Q38253502 | ||
| Pluripotent stem cells and tolerance induction in organ transplantation. | Q38293166 | ||
| Methods of induced pluripotent stem cells for clinical application | Q38332490 | ||
| Cell therapy in Duchenne muscular dystrophy treatment: clinical trials overview. | Q38467615 | ||
| Competence of in vitro cultured mouse embryonic stem cells for myogenic differentiation and fusion with myoblasts. | Q38983512 | ||
| An ex vivo gene therapy approach to treat muscular dystrophy using inducible pluripotent stem cells | Q39456951 | ||
| Complete genetic correction of ips cells from Duchenne muscular dystrophy | Q39641162 | ||
| Marked differences in differentiation propensity among human embryonic stem cell lines | Q40012772 | ||
| Derivation of engraftable skeletal myoblasts from human embryonic stem cells | Q40225312 | ||
| Skeletal myogenesis by human embryonic stem cells | Q40264797 | ||
| In vitro modeling of paraxial and lateral mesoderm differentiation reveals early reversibility | Q40341495 | ||
| Use of developmental marker genes to define temporal and spatial patterns of differentiation during embryoid body formation | Q40948033 | ||
| Myoblasts derived from normal hESCs and dystrophic hiPSCs efficiently fuse with existing muscle fibers following transplantation | Q41136531 | ||
| Pax3 regulation of FGF signaling affects the progression of embryonic progenitor cells into the myogenic program | Q41299236 | ||
| Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents | Q41456800 | ||
| Muscle determination: another key player in myogenesis? | Q41642300 | ||
| Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells | Q41823910 | ||
| A zebrafish embryo culture system defines factors that promote vertebrate myogenesis across species. | Q41892400 | ||
| Embryonic stem cell differentiation models: cardiogenesis, myogenesis, neurogenesis, epithelial and vascular smooth muscle cell differentiation in vitro. | Q41946940 | ||
| Myogenic differentiation of muscular dystrophy-specific induced pluripotent stem cells for use in drug discovery | Q41956611 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pluripotency | Q1894941 |
| cell | Q7868 | ||
| physiological phenomenon | Q66615932 | ||
| P304 | page(s) | 363-375 | |
| P577 | publication date | 2015-12-01 | |
| P1433 | published in | Journal of Muscle Research & Cell Motility | Q13739445 |
| P1476 | title | From pluripotency to myogenesis: a multistep process in the dish | |
| P478 | volume | 36 |
| Q48265121 | A process engineering approach to increase organoid yield |
| Q91714852 | Adipose Tissue-Derived Stromal Cells in Matrigel Impacts the Regeneration of Severely Damaged Skeletal Muscles |
| Q37409410 | Cell cycle regulation of embryonic stem cells and mouse embryonic fibroblasts lacking functional Pax7. |
| Q46125088 | Embryonic-only arsenic exposure in killifish (Fundulus heteroclitus) reduces growth and alters muscle IGF levels one year later |
| Q38748704 | Generation of human muscle fibers and satellite-like cells from human pluripotent stem cells in vitro |
| Q42584621 | Insight into muscle physiology through understanding mechanisms of muscle pathology. |
| Q92619318 | Interleukin 4 Moderately Affects Competence of Pluripotent Stem Cells for Myogenic Conversion |
| Q41510232 | Stem cells migration during skeletal muscle regeneration - the role of Sdf-1/Cxcr4 and Sdf-1/Cxcr7 axis |
Search more.